The EVERSANA Medical Science Liaison/Senior Medical Science Liaison (MSL/Sr. MSL) functions as a highly trained, field-based scientific expert in targeted therapy, who engages healthcare professionals and leaders in clinical, scientific, value-based care and research-based peer-to-peer scientific exchange around solid tumor combination therapy, specifically in cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC).
Following regulatory and corporate guidelines, they will facilitate and build scientific relationships and collaborations with the oncology scientific community. This position interacts with local, regional, and national Key Opinion Leaders (KOLs) and healthcare practitioners (HCPs), as well as professional societies and organizations.
The EVERSANA MSL/Sr. MSL will need to be fully engaged with pertinent professional societies, as well as other value-based institutions and associations including clinics and centers involved in the treatment of CCA and HCC and the delivery of immunotherapy. The MSL will be the field-based scientific expert regarding our client’s product.
ESSENTIAL DUTIES AND
RESPONSIBILITIES:
- Function as the primary point of contact within the assigned geographic area.
- Maintain clinical and scientific, expertise in oncology and immunotherapy with specific focus in standards of care related to the treatment of CCA and HCC.
- Engage in well informed, compliant, robust, and accurate scientific peer exchange around our client’s pipeline, with KOLs.
- Maintain a thorough understanding of the clinical protocols, clinical trials outcomes and related procedures.
- Develop and track key opinion leader (KOL) engagement plans - identify, develop, and maintain long-term collaborative relationships with KOLs within assigned region.
- Engage in medical & scientific exchange with the medical/scientific community including advisory boards.
- Manage ongoing territory planning, development, and engagement activities.
- Manage all clinical program requests and respond to unsolicited requests for information.
- Collaborate with R&D Team to support sites and investigators participating in the company-sponsored clinical trials.
- Conduct pre-launch KOL profiling efforts to enhance depth of product/disease/scientific knowledge. Facilitate top account/institution profiling efforts to enhance understanding of patient care pathways, including treatment protocol development and novel therapies.
- Work collaboratively and compliantly with commercial colleagues to assure product strategic imperatives are represented cross functionally in account engagement,
- Respond to and document unsolicited requests for information on clinical initiatives.
- May serve as a resource for investigator sponsored trial (IIT) proposal.
- Provide internal teams with feedback and insights from interactions with KOLs.
- Represent our client at medical meetings through Medical Affairs’ Scientific Booth coverage and other related activities.
- Attend congresses as appropriate and develop meaningful internal reports of the congresses covered.
- Adhere to corporate SOPs and ensure vigilant compliance with relevant legal and regulatory guidelines governing scientific interactions with physicians and healthcare professionals across all activities, including those related to clinical trials, scientific interactions with internal and external groups, and responses to unsolicited requests for medical/scientific information.
- Consistently demonstrate a high standard of excellence in the management of assigned territory while also contributing to the success of colleagues and the MSL team.
- Contribute to the achievement of organizational goals beyond the borders of assigned geographic territory.
- Maintain expertise in clinical data and effectively communicate the scientific and clinical outcomes, economic, and value-based evidence supporting our client's products to healthcare professionals, formulary committee members, and payers.
- Provide medical support, clinical input, and/or training for internal teams as requested. #LI-CG1
PREFERRED
QUALIFICATIONS:
- An advanced degree (e.g., PharmD, PhD, MD, MSN, or NP/PA) is required.
- MSL : A minimum of 2 years previous MSL experience necessary with a minimum of 1 year in rare disease, oncology (and/or immunology) with working knowledge of targeted therapies.
- Sr. MSL : A minimum of 5 years of pharma experience and 3 years of rare disease, oncology (and/ or immunology) experience.
- Gi Cancer Therapy experience is strongly preferred.
- Prior product launch experience required.
- Exhibits the highest level of scientific, business, and clinical acumen with excellent communication and networking skills.
- The ability to interpret and present scientific data to engage KOLs.
- Working knowledge of standards of care for HCC and CCA is desirable.
- Previous experience sharing scientific content with payer systems is highly desirable.
- Working knowledge of NCI Cooperative Groups and Oncology Research Consortiums.
- Ability to present complex scientific and evidence-based data to payors and/or formulary committees is required.
- Working knowledge of institutions and clinics in selected geographies is expected.
- Excellent written and oral presentation skills.
- Ability to travel frequently (70%) with overnight stays (e.g., KOL meetings, site locations, internal meetings, medical meetings and congresses, training).